FINANCIAL NEWS

ASX Winners And Losers Of Today – 30-10-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

6:35 PM


Next Week At A Glance – 2-6 Nov 2026

A brief look at important company events and economic data releases next week

12:05 PM


In Case You Missed It – BC Extra Upgrades & Downgrades – 30-10-26

A summary of the highlights from Broker Call Extra updates throughout the week past

11:00 AM


Weekly Top Ten News Stories – 30 October 2026

Our top ten news stories from 22 October 2026 to 29 October 2026

10:45 AM


Australian Broker Call *Extra* Edition – Oct 30, 2026

Extra Edition of the Broker Call Report

10:30 AM


Macquarie rates FRW as Outperform

First quarter earnings from Freightways rose 12.9%, which Macquarie assesses was a resilient outcome amidst subdued freight markets. Revenue rose 17.6% and net profit 12.0%, while the quality of growth was mixed.

The broker points out underlying activity remains soft and while acquisitions, market share and efficiency continue to lead, a cyclical recovery is dependent on lower fuel prices. Outperform rating and NZ$15.65 target.

Macquarie rates LTR as Outperform

Liontown's September-quarter production missed the consensus estimate by around -20%, with underground ramp-up challenges overshadowing stronger sales and revenue, Macquarie explains.

The broker lowers its FY27 production to near the bottom of unchanged guidance, reflecting a conservative ramp-up outlook.

Near-term spodumene price assumptions fall -31–36%, contributing to the analyst's FY27–FY31 earnings per share forecast cuts ranging from -10% to over -100%. A loss is now expected in FY27.

The target falls -38% to $0.75 from $1.20 on the weaker earnings outlook. Macquarie retains an Outperform rating.

Citi rates SUN as Neutral

Suncorp Group has briefed investors on the third phase of what it considers is the way towards a simplified insurer. Citi finds it hard to evaluate at this stage whether there are meaningful competitive advantages that will have a sustainable impact on earnings prospects.

GWP growth guidance was also trimmed to 3% from 3%-5%, allowing for a more adverse AUD:NZD exchange rate and a lost commercial contract of -$125m.

Still, underlying growth appears to be tracking a little better than the broker previously forecast.

The underlying insurance margin guidance is unchanged at the top half of a 10%-12% range. Citi revises EPS estimates down by -1% for FY27 and up by 0.3% for FY28.

Neutral. Target edges down to $19.75 from $19.80.

Click here to see full report market arrow icon

ANALYSIS & DATA

FNARENA'S MARKET CONSENSUS FORECASTS

To display the stock analysis for a company please enter the company code:

ANZ | ANZ GROUP HOLDINGS LIMITED

Abbreviated format - see the full version here


LAST PRICECHANGE +/-CHANGE %VOLUME

$40.72

29 Oct
2026

market green arrow 0.860

OPEN

$40.05

market green arrow 2.16%

HIGH

$40.77

4,021,395

LOW

$39.88

TARGET
$36.073-11.4% downside
Franking for last dividend paid out: 75%
FNARENA'S MARKET CONSENSUS FORECASTS
ANZ: 1
TitleFY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps)xxx 198.2 247.9xxx
DPS (cps)xxx 166.0 166.7xxx
EPS Growthxxx- 9.1% 25.1%xxx
DPS Growthxxx 0.0% 0.4%xxx
PE RatioxxxN/A 16.5xxx
Dividend YieldxxxN/A 4.1%xxx
Div Pay Ratio(%)xxx 83.8% 67.2%xxx

FOLLOW US ON SOCIAL MEDIA

9.2K Followers
27.2K Posts
@Filapek
Rudi Filapek-Vandyck@Filapek
8h
RBC Capital on ResMed $RMD: "RMD delivered a strong 1Q27 which beat on revenues and gross margins. "While this result did benefit from the delayed phasing of supply chain investments and elevated RoW device sales that will roll-off in the 2H, we like the company's growth being
@Filapek
Rudi Filapek-Vandyck@Filapek
1h
RBC Capital on Coles Group $COL : "A disappointing update - we think the market will focus on 1) likely market share losses in Supermarkets with COL reporting +2.7% comp sales growth vs RBCe +3.2%, and further moderation in October compared to 1Q27 (current RBCe 2Q27 forecast is
@Filapek
Rudi Filapek-Vandyck@Filapek
1h
RBC Capital on ResMed $RMD: "RMD has delivered a strong result that has beat RBCe and consensus across all key line items. "The company has delivered strong revenue performance across all categories. "Non-GAAP gross margin expanded by 20bps sequentially, which beat
@Filapek
Rudi Filapek-Vandyck@Filapek
15h
Rudi's View: High Conviction ASX Opportunitieshttps://t.co/QowNhmaoX1#ASX#stocksinfocus#investing@FNArena
@Filapek
Rudi Filapek-Vandyck@Filapek
18h
Canaccord Genuity on SiteMinder $SDR: "We are upgrading SDR to BUY and lifting our price target to $4.10. "It has been a difficult CYTD for shareholders, with AI-driven uncertainty around SaaS business models compounded by higher interest rates and waning investor appetite for
@Filapek
Rudi Filapek-Vandyck@Filapek
18h
From today's Australian Broker Call Report @FNArena : They have certainly taken their time, but analysts at Citi today cut their target for NextDC to $12.75 from $21.15, reflecting delayed M3 billing, higher funding costs and the removal of future projects from forecasts. The
@Filapek
Rudi Filapek-Vandyck@Filapek
20h
From today's Australian Broker Call Report @FNArena : First response: Citi maintains a Neutral rating and $8.10 target for IGO, balancing record Greenbushes production against ongoing concerns over cash distributions from Tianqi Lithium Energy Australia (TLEA). September
@Filapek
Rudi Filapek-Vandyck@Filapek
22h
RBC Capital on Integral Diagnostics $IDX : "IDX has provided a disappointing trading update with lower-than-expected 1Q revenue growth in the Australian and New Zealand businesses, staff shortages impacting revenue growth, higher costs leading to a downgrade in FY27 EBITDA
@Filapek
Rudi Filapek-Vandyck@Filapek
23h
Citi on Wesfarmers $WES: "Wesfarmers' AGM trading update indicates that Bunnings has seen deteriorating sales trends since August. "Sales are tracking below 2H26e (2.4%) on weaker seasonal and commercial sales in recent weeks. This is despite sales growth tracking ahead of
@Filapek
Rudi Filapek-Vandyck@Filapek
23h
RBC Capital on Super Retail $SUL: "LFL sales trends appear weak across the board with all segments having deteriorated since the first 7 weeks update. "We roughly estimate (based on intra-period interpolation) that group LFL sales has deteriorated from +1.5% growth in the first
FIND FNARENA ON

DAILY FINANCIAL NEWS

Fraud Fallout: Analysts Back Zip

While Zip Co’s fraud losses and rising US bad debts rattled investors, accelerating growth and unchanged guidance keep analysts positive

Oct 29 2026 - Small Caps


Cuscal’s unique position in Australia’s payments infrastructure market offers attractive earnings growth, supported by high barriers to entry, operating leverage and acquisitions

Oct 29 2026 - Small Caps


Whitehaven Coal started FY27 on a strong footing, with higher coal prices adding to the upside, but pending production disruptions and seasonality suggest more challenges are ahead

Oct 28 2026 - Commodities


BlueScope Steel’s earnings upgrade highlights its exposure to a tightening US steel market, raising hopes for greater shareholder returns

Oct 28 2026 - Australia


The Federal Court has ordered Hollard Insurance to pay a $2 million penalty over delays in handling a home insurance claim, putting claims handling firmly in the regulatory spotlight

Oct 28 2026 - Australia


Sigma Healthcare is expanding at home and abroad, with oral GLP-1 medicines offering further upside

Oct 27 2026 - Australia


rudi fnarena picture

RUDI'S VIEWS

Rudi’s View: High Conviction ASX Opportunities

In this week’s edition: Fundies Selling Resources, Opportunities In Small Caps, Noosa Conference Standouts & December Index Changes

Oct 29 2026

DAILY MARKET REPORTS

ASX Winners And Losers Of Today – 30-10-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

6:35 PM


Australian Broker Call *Extra* Edition – Oct 30, 2026

Extra Edition of the Broker Call Report

10:30 AM


The Overnight Report: US Tech Results Disappoint

A global perspective on what happened overnight

8:53 AM


Today’s Financial Calendar – 30-10-2026

Significant Scheduled Events For 30 October, 2026

8:15 AM


ASX Winners And Losers Of Today – 29-10-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Oct 29 2026


The Overnight Report: Rate Hike(s) Coming

A global perspective on what happened overnight

Oct 29 2026


Today’s Financial Calendar – 29-10-2026

Significant Scheduled Events For 29 October, 2026

Oct 29 2026


WEEKLY REPORTS

Next Week At A Glance – 2-6 Nov 2026

A brief look at important company events and economic data releases next week

12:05 PM

In Case You Missed It – BC Extra Upgrades & Downgrades – 30-10-26

A summary of the highlights from Broker Call Extra updates throughout the week past

11:00 AM

Weekly Top Ten News Stories – 30 October 2026

Our top ten news stories from 22 October 2026 to 29 October 2026

10:45 AM


In Brief: Benz Mining, Cobram, Advanced Innergy

In this week’s In Brief, three initiations on a mega-scale WA gold developer, Australia’s premier olive oil producer, and an offshore energy materials specialist

10:00 AM

The Short Report – 29 Oct 2026

FNArena’s weekly update on short positions in the Australian share market

Oct 29 2026

Weekly Update On LICs & LITs – 26-Oct-2026

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Oct 27 2026


Uranium Week: U308 Joins Sell The AI Trade

As the world decided to abandon the popular AI trade, ASX-listed uranium stocks got dragged down too. Elevated short positions can potentially trigger a short-covering rally when momentum turns

Oct 27 2026

Australian Listed Real Estate Tables – 26-10-2026

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

Oct 26 2026

Weekly Ratings, Targets, Forecast Changes – 23-10-26

Weekly update on stockbroker recommendation, target price, and earnings forecast changes

Oct 26 2026


9.2K Followers
27.2K Posts
@Filapek
Rudi Filapek-Vandyck @Filapek
3h
RBC Capital on ResMed $RMD: "RMD delivered a strong 1Q27 which beat on revenues and gross margins. "While this result did benefit from the delayed phasing of supply chain investments and elevated RoW device sales that will roll-off in the 2H, we like the company's growth being
@Filapek
Rudi Filapek-Vandyck @Filapek
9h
RBC Capital on Coles Group $COL : "A disappointing update - we think the market will focus on 1) likely market share losses in Supermarkets with COL reporting +2.7% comp sales growth vs RBCe +3.2%, and further moderation in October compared to 1Q27 (current RBCe 2Q27 forecast is
@Filapek
Rudi Filapek-Vandyck @Filapek
12h
RBC Capital on ResMed $RMD: "RMD has delivered a strong result that has beat RBCe and consensus across all key line items. "The company has delivered strong revenue performance across all categories. "Non-GAAP gross margin expanded by 20bps sequentially, which beat
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
Rudi's View: High Conviction ASX Opportunities https://t.co/QowNhmaoX1 #ASX #stocksinfocus #investing @FNArena
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
Canaccord Genuity on SiteMinder $SDR: "We are upgrading SDR to BUY and lifting our price target to $4.10. "It has been a difficult CYTD for shareholders, with AI-driven uncertainty around SaaS business models compounded by higher interest rates and waning investor appetite for
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
From today's Australian Broker Call Report @FNArena : They have certainly taken their time, but analysts at Citi today cut their target for NextDC to $12.75 from $21.15, reflecting delayed M3 billing, higher funding costs and the removal of future projects from forecasts. The
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
From today's Australian Broker Call Report @FNArena : First response: Citi maintains a Neutral rating and $8.10 target for IGO, balancing record Greenbushes production against ongoing concerns over cash distributions from Tianqi Lithium Energy Australia (TLEA). September
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
RBC Capital on Integral Diagnostics $IDX : "IDX has provided a disappointing trading update with lower-than-expected 1Q revenue growth in the Australian and New Zealand businesses, staff shortages impacting revenue growth, higher costs leading to a downgrade in FY27 EBITDA
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
Citi on Wesfarmers $WES: "Wesfarmers' AGM trading update indicates that Bunnings has seen deteriorating sales trends since August. "Sales are tracking below 2H26e (2.4%) on weaker seasonal and commercial sales in recent weeks. This is despite sales growth tracking ahead of
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
RBC Capital on Super Retail $SUL: "LFL sales trends appear weak across the board with all segments having deteriorated since the first 7 weeks update. "We roughly estimate (based on intra-period interpolation) that group LFL sales has deteriorated from +1.5% growth in the first
FIND FNARENA ON

THE MARKETS

    Click item/line to change chart

  • Australia

    30 October 2026   Updated : 19:41   AEDT

    SPI Overnight

    8937.00

    +32.00

    0.36%

    NZ50

    13797.000

    +86.830

    0.630%

    All Ordinaries

    9025.40

    +12.80

    0.14%

    S&P ASX 200

    8908.10

    +16.30

    0.18%

    S&P ASX 300

    8813.70

    +14.40

    0.16%

    Communication Services

    1588.10

    +12.50

    0.79%

    Consumer Discretionary

    3683.70

    +98.00

    2.73%

    Consumer Staples

    13177.70

    -128.90

    -0.97%

    Energy

    11056.20

    +106.20

    0.97%

    Financials

    9823.70

    +14.00

    0.14%

    Health Care

    34777.80

    +288.20

    0.84%

    Industrials

    8226.10

    +93.10

    1.14%

    Info Technology

    1621.00

    -22.00

    -1.34%

    Materials

    22212.60

    -194.30

    -0.87%

    Real Estate

    3362.90

    +9.00

    0.27%

    Utilities

    10730.10

    +71.40

    0.67%

    A-REITs

    1569.80

    +4.40

    0.28%

    All Technology Index

    2818.80

    -21.50

    -0.76%

    Banks

    4142.50

    +0.10

    0.00%

    Gold Index

    17080.60

    -378.50

    -2.17%

    Metals & Mining

    7583.00

    -85.70

    -1.12%

    Click item/line to change chart

  • Australasia

    30 October 2026   Updated : 19:41   AEDT

    AUD/USD

    0.7026

    0.00

    -0.17%

    AUD/NZD

    1.2443

    -0.01

    -0.64%

    NZD/USD

    0.5647

    +0.00

    0.48%

    AUD/JPY

    110.48

    -0.60

    -0.54%

    SGD/AUD

    1.11

    +0.00

    0.42%

    AUD/EUR

    0.6274

    0.00

    -0.71%

    AUD/GBP

    0.5238

    0.00

    -0.93%

    AUDCAD

    0.9810

    0.00

    -0.37%

  • World

    30 October 2026   Updated : 19:41   AEDT

    CAD/USD

    0.7162

    +0.00

    0.22%

    EUR/JPY

    176.10

    +0.30

    0.17%

    EUR/USD

    1.1199

    +0.01

    0.54%

    GBP/USD

    1.3413

    +0.01

    0.77%

    USD/JPY

    157.25

    -0.58

    -0.37%

    Click item/line to change chart

  • World

    30 October 2026   Updated : 19:41   AEDT

    FTSE100

    10764.60

    +42.53

    0.40%

    DAX30

    25971.04

    -68.64

    -0.26%

    Hang Seng

    23294.42

    +335.77

    1.46%

    Nikkei 225

    63290.11

    -1369.36

    -2.12%

    NZ50

    13797.000

    +86.830

    0.630%

    DJIA

    52342.56

    -132.54

    -0.25%

    S&P500

    7720.39

    -23.59

    -0.30%

    Nasdaq Comp

    26184.73

    -365.13

    -1.38%

    S&P500 VIX

    18.56

    +1.65

    9.76%

    US 10-year yield

    4.989

    -0.056

    -1.110%

    USD Index

    102.13

    -0.17

    -0.17%

  • Aus Stocks

    30 October 2026   Updated : 19:41   AEDT

    Amcor (US)

    47.13

    +1.45

    3.17%

    Newmont (US)

    111.80

    -2.12

    -1.86%

    Rio Tinto (UK)

    6202.00

    -4.00

    -0.06%

    BHP Group (US)

    81.82

    -0.44

    -0.53%

    Rio Tinto (US)

    83.25

    -2.68

    -3.12%

    ResMed (US)

    252.83

    +2.66

    1.06%

    South32 (UK)

    227.00

    -0.60

    -0.26%

    James Hardie (US)

    26.94

    +0.88

    3.38%

    Janus Henderson (US)

    51.95

    -0.02

    -0.04%

    Click item/line to change chart

  • Metals & Minerals

    29 October 2026   Updated : 07:22   AEDT

    Gold (oz)

    4067.26

    +5.04

    0.12%

    Silver (oz)

    54.16

    -0.30

    -0.55%

    Copper (lb)

    6.6700

    +0.04

    0.60%

    Aluminium (lb)

    1.3966

    +0.01

    1.01%

    Nickel (lb)

    7.0027

    -0.05

    -0.64%

    Zinc (lb)

    1.7818

    +0.01

    0.70%

    Copper (t)

    14700.68

    +88.16

    0.60%

    Aluminium (t)

    3078.00

    +30.50

    1.00%

    Nickel (t)

    15434.00

    -100.00

    -0.64%

    Zinc (t)

    3927.00

    +27.00

    0.69%

    Uranium (lb) weekly

    89.75

    -0.25

    -0.28%

    Iron Ore (t)

    90.70

    -0.08

    -0.09%

  • Energy

    29 October 2026   Updated : 07:22   AEDT

    West Texas Crude

    101.73

    +1.72

    1.72%

    Brent Crude

    113.95

    -0.36

    -0.31%

CALENDAR

Friday, 30 October 2026
NZ Oct ANZ consumer confidence
AU 3Q PPI
AU Sep Private sector credit
JP BoJ rate
JP Oct Tokyo CPI
JP Sep Industrial production (prelim)
JP Sep Retail sales
JP Sep Unemployment
EZ 3Q GDP (advance)
EZ Oct ECB Kocher speech
EZ Sep Unemployment
US Oct Chicago PMI
US Oct Fed Daly introductory remarks

ALL WEATHER STOCKS

CodeCompanyPrice
CARCAR GROUP LIMITED

market icon up$24.50

REAREA GROUP LIMITED

market icon up$159.48

RMDRESMED INC

market icon up$35.51

TNETECHNOLOGY ONE LIMITED

market icon down$31.73

WOWWOOLWORTHS GROUP LIMITED

market icon up$40.22

WEEKLY PDF

Stories To Read From FNArena


WEEK 44
icon pdf

WEEK 43
icon pdf

WEEK 42
icon pdf

WEEK 41
icon pdf

WEEK 40
icon pdf

FNARENA TALKS

FNARENA WINDOWS

Window on BUSINESS & CONSUMER CREDIT

Fraud Fallout: Analysts Back Zip

While Zip Co’s fraud losses and rising US bad debts rattled investors, accelerating growth and unchanged guidance keep analysts positive

Oct 29 2026


Window on DIVERSIFIED FINANCIALS

Cuscal’s Payments Moat & Premium Valuation

Cuscal’s unique position in Australia’s payments infrastructure market offers attractive earnings growth, supported by high barriers to entry, operating leverage and acquisitions

Oct 29 2026


Window on COAL

Divided Views Post Whitehaven’s Q1 Performance

Whitehaven Coal started FY27 on a strong footing, with higher coal prices adding to the upside, but pending production disruptions and seasonality suggest more challenges are ahead

Oct 28 2026


GEN AI

NextDC’s Collision With The Real World

The global AI infrastructure boom is colliding with real-world constraints, forcing NextDC to issue a shock profit warning last week

Oct 26 2026


FEATURE STORIES

History’s Blue Print For The AI Investment Cycle

Artificial intelligence remains a polarising subject, but Australia is strategically well positioned to benefit. So, how should investors be positioned in the AI cycle?

Oct 01 2026